Widespread population immunity from prior SARS-CoV-2 infections and updated vaccines, combined with the virus’s transition to endemic seasonal circulation resembling influenza, underpins the 96.2% market-implied probability against a new coronavirus pandemic in 2026. Official WHO assessments rate the global risk as moderate, with no public health emergency of international concern declared since 2023 and current variants such as XFG Omicron showing limited virulence. Late-summer 2026 surges reported by CDC and European surveillance reflect typical patterns but produce far lower hospitalization and death rates than earlier waves. A novel, highly transmissible zoonotic coronavirus or unexpectedly virulent mutation could still shift outcomes before year-end, though current genomic and epidemiological data show no such developments.